Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Seyed Hamidolah Ghaffari"'
Autor:
Mahdi Jalili, Massoud Iravani, Kamran Alimoghaddam, Seyed Asadollah Mousavi, Ardeshir Ghavamzadeh, Mohamad Jahani, Babak Bahar, Shahrbano Rostami, Seyed Hamidolah Ghaffari
Publikováno v:
Journal of Clinical Oncology. 29:2753-2757
Purpose The long-term follow-up results of patients with acute promyelocytic leukemia (APL) treated with all-trans retinoic acid and chemotherapy show high cure rates. Several studies have shown high efficacy of single-agent arsenic trioxide in newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28c2dbc1e7e5216f6e109868007779b1
https://doi.org/10.1200/jco.2010.32.2107
https://doi.org/10.1200/jco.2010.32.2107
Autor:
Ali Akbar Pourfathollah, Somayeh Shahrokhi, Massoumeh Ebtekar, Mahboobeh Mohseni, Maryam Kheirandish, Zohreh Sharifi, Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Seyed Hamidolah Ghaffari
Publikováno v:
Neuropeptides. 44(5)
Background Modulation of the expression of CXCR4 as a critical adhesion molecule on cord blood (CB) CD34 + cells could overcome delay following cord blood transplantation. Identification of beneficial effects of growth factors including cytokines and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e7a1057fc7fed28cc3dc2f2be1f243
https://pubmed.ncbi.nlm.nih.gov/20599269
https://pubmed.ncbi.nlm.nih.gov/20599269
Autor:
Mohsen Esfandbod, Ardeshir Ghavamzadeh, Mohammad Vaezi, Kamran Alimoghaddam, Shahrbano Rostami, Mohammad Jahani, Seyed Asadollah Mousavi, Seyed Hamidolah Ghaffari, Babak Bahar, Mahdi Jalili
Publikováno v:
Journal of Clinical Oncology. 31:7069-7069
7069 Background: The first line therapy strategy remains controversial in acute promyelocytic leukemia (APL) patients. Arsenic trioxide (AS2O3) approved in relapsed or resistance patients and recently studies reveals benefits of AS2O3in first line th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd4fbdd170b2f2e75c1bdbb56778b5f9
https://doi.org/10.1200/jco.2013.31.15_suppl.7069
https://doi.org/10.1200/jco.2013.31.15_suppl.7069
Autor:
Seyed Hamidolah Ghaffari, Kamran Alimoghaddam, Seyed Asadollah Mousavi, Mohamad Jahani, Masood Iravani, Eisa Baybordi, Mahdi Jalili, Shahrbano Rostami, Nassrin Alizadeh, Ardeshir Ghavamzadeh, Babak Bahar
Publikováno v:
Blood. 116:506-506
Abstract 506 Long term follow-up of APL patients treated by ATRA and chemotherapy is available and shows promising results of DFS and OS. Although several studies show acceptable efficacy of Arsenic Trioxide in new cases of APL, its long term result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5e744de890f2f70f9319cce67aa2e0d
https://doi.org/10.1182/blood.v116.21.506.506
https://doi.org/10.1182/blood.v116.21.506.506
Autor:
Ahmad Reza Shamshiri, Ardeshir Ghavamzadeh, Mahdi Jalili, Kamran Alimoghaddam, Omid Yeganeh, Seyed Hamidolah Ghaffari, Shahrbano Rostami
Publikováno v:
Blood. 114:4682-4682
Abstract 4682 Introduction Inactivation of tumor suppressor genes P15 & P16 due to Hypermethylation has a critical role in progression of cancer. We analyzed the meltylation status of promoter region of these two genes and their correlation with pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdd33b745cc9e9d53be2ff42d078c755
https://doi.org/10.1182/blood.v114.22.4682.4682
https://doi.org/10.1182/blood.v114.22.4682.4682
Autor:
Ardeshir Ghavamzadeh, Massoud Iravani, Babak Bahar, Seyed Asadollah Mossavi, Seyed Hamidolah Ghaffari, Kamran Alimoghaddam, Zahra Nasri Moghadam, Ezat Eini, Mehrangiz Tootonchi, Mohamad Jahani, A Khodabandeh, Shahrbano Rostami, Parvin Radsafa, Fakhri Afshar, Rohollah Hosseini, Eissa Baybordi
Publikováno v:
Blood. 112:140-140
Acute promyelocytic leukemia (APL) is a unique type of hematologic malignancies with high cure rate. ATRA and chemotherapy is current standard treatment but Arsenic Trioxide (ATO) is most potent single agent against APL. Materials and methods: betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84cf2411caf5b138b4c793e39948a0c7
https://doi.org/10.1182/blood.v112.11.140.140
https://doi.org/10.1182/blood.v112.11.140.140
Autor:
Ardeshir Ghavamzadeh, Seyed Hamidolah Ghaffari, Abdolhamid Jamialahmadi, Nilofar Shayan-Asl, Kamran Alimoghaddam
Publikováno v:
Blood. 110:4236-4236
Introduction: The telomeric DNA together with its associated proteins protects the chromosome ends from degradation or aberrant recombination. Telomerase and telomere are extensively investigated as potential diagnostic and prognostic markers in huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f42b409013a4b194db8a9d689781fce7
https://doi.org/10.1182/blood.v110.11.4236.4236
https://doi.org/10.1182/blood.v110.11.4236.4236
Autor:
Ardeshir Ghavamzadeh, Somayeh Shahrokhi, Seyed Hamidolah Ghaffari, N Bagheri, Alireza Ardjmand, Leili Moezzi, Bahram Chardouli, Kamran Alimoghaddam
Publikováno v:
Scopus-Elsevier
Hematology/Oncology and Stem Cell Therapy, Vol 3, Iss 1, Pp 18-23 (2010)
Hematology/Oncology and Stem Cell Therapy, Vol 3, Iss 1, Pp 18-23 (2010)
BACKGROUND Dendritic cells (DCs) play a critical role in the immune response and are a candidate for immunotherapy in cancer. Since gibbon ape leukemia virus (GALV) transduction of CD34 + cells is reasonably efficacious, we asessed the efficacy of GA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4048f012a9974d460916c875e32b4c0
http://www.scopus.com/inward/record.url?eid=2-s2.0-77953677180&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-77953677180&partnerID=MN8TOARS
